StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note issued to investors on Wednesday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens upped their price objective on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st.
Get Our Latest Stock Analysis on Veradigm
Veradigm Stock Up 5.0 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Must-Have ETFs Set to Dominate This Quarter
- How to Most Effectively Use the MarketBeat Earnings Screener
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Find Undervalued Stocks
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
